A

AFFiRiS AG

250 employees

AFFiRiS develops tailor-made peptide vaccines for alzheimer's, parkinson's, atheroclerosis, hypertension and several other conditions.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neurodegenerative diseases
Alzheimer’s disease
Dementia with Lewy Bodies
Huntington's Disease
Immunotherapy
Multiple System Atrophy
Medical
Pharmaceutical
Parkinson’s disease

Date founded

2003

Funding rounds raised

Total raised

$34M

from 5 investors over 5 rounds

A

AFFiRiS AG raised $11M on April 25, 2017

Investors: MIG Capital

A

AFFiRiS AG raised $10M on June 28, 2016

Investors: Santoholding, MIG Capital and ARAX Capital Partners GmbH

A

AFFiRiS AG raised $34M on November 9, 2011

Investors: MIG Capital

FAQ